- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 353.64M sh |
| Shares Diluted | Q1 2025 · Mar 29, 2025 | 357.07M sh |
| Shares Diluted | Q1 2025 · Mar 30, 2024 | 351.58M sh |
| Capex | Q1 2025 · Mar 29, 2025 | $11.25M |
| Capex | Q1 2025 · Mar 30, 2024 | $20.26M |
| Operating Cash Flow | Q1 2025 · Mar 29, 2025 | −$108.18M |
| Operating Cash Flow | Q1 2025 · Mar 30, 2024 | $26.17M |
| Long Term Debt | Q1 2025 · Mar 29, 2025 | $2.32B |
| Long Term Debt | Q1 2025 · Dec 28, 2024 | $2.19B |
| Long Term Debt | Q1 2025 · Mar 30, 2024 | $3.24B |
| Cash And Equivalents | Q1 2025 · Mar 29, 2025 | $175.94M |
| Cash And Equivalents | Q1 2025 · Dec 28, 2024 | $214.85M |
| Cash And Equivalents restated | Q1 2025 · Mar 30, 2024 | $176M |
| Stockholders Equity | Q1 2025 · Mar 29, 2025 | $43.45M |
| Stockholders Equity | Q1 2025 · Dec 28, 2024 | $34.01M |
| Stockholders Equity | Q1 2025 · Mar 30, 2024 | $338.17M |
| Stockholders Equity | Q1 2025 · Dec 30, 2023 | $419.35M |
| Current Liabilities | Q1 2025 · Mar 29, 2025 | $1.11B |
| Current Liabilities | Q1 2025 · Dec 28, 2024 | $1.25B |
| Current Liabilities | Q1 2025 · Mar 30, 2024 | $1.46B |
| Total Liabilities | Q1 2025 · Mar 29, 2025 | $3.78B |
| Total Liabilities | Q1 2025 · Dec 28, 2024 | $3.81B |
| Total Liabilities | Q1 2025 · Mar 30, 2024 | $5.25B |
| Current Assets | Q1 2025 · Mar 29, 2025 | $1.71B |
| Current Assets | Q1 2025 · Dec 28, 2024 | $1.72B |
| Current Assets | Q1 2025 · Mar 30, 2024 | $2.32B |
| Total Assets | Q1 2025 · Mar 29, 2025 | $3.82B |
| Total Assets | Q1 2025 · Dec 28, 2024 | $3.84B |
| Total Assets | Q1 2025 · Mar 30, 2024 | $5.59B |
| Eps Diluted | Q1 2025 · Mar 29, 2025 | −$0.03 |
| Eps Diluted | Q1 2025 · Mar 30, 2024 | −$0.11 |
| Eps Basic | Q1 2025 · Mar 29, 2025 | −$0.03 |
| Eps Basic | Q1 2025 · Mar 30, 2024 | −$0.11 |
| Sga Expense | Q1 2025 · Mar 29, 2025 | $236.79M |
| Sga Expense restated | Q1 2025 · Mar 30, 2024 | $262.02M |
| Net Income | Q1 2025 · Mar 29, 2025 | −$9.46M |
| Net Income | Q1 2025 · Mar 30, 2024 | −$39.12M |
| Operating Income | Q1 2025 · Mar 29, 2025 | $79.91M |
| Operating Income restated | Q1 2025 · Mar 30, 2024 | $35.41M |
| Gross Profit | Q1 2025 · Mar 29, 2025 | $316.7M |
| Gross Profit restated | Q1 2025 · Mar 30, 2024 | $297.43M |
| Cost Of Revenue | Q1 2025 · Mar 29, 2025 | $443.45M |
| Cost Of Revenue restated | Q1 2025 · Mar 30, 2024 | $447.24M |
| Revenue | Q1 2025 · Mar 29, 2025 | $760.15M |
| Revenue restated | Q1 2025 · Mar 30, 2024 | $744.68M |